India Pharmas, U.S. FDA Agree On Talks, Workshops To Address Problems
This article was originally published in PharmAsia News
Executive Summary
The Indian Pharmaceutical Alliance and the U.S. FDA have agreed to conduct joint workshops and hold discussions with the 19 member drug makers to help them avoid some of the stern responses to violations.